CLINICAL_TRIALS
trial_result
· 2025-04-04
Clinical Trial Update: Study of Tamibarotene in Patients With ADPKD [Phase 2]
Summary
Phase 2 clinical trial evaluating tamibarotene for Autosomal Dominant Polycystic Kidney Disease (ADPKD) is currently active but not recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Rege Nephro Co., Ltd. | Conditions: Autosomal Dominant Polycystic Kidney Disease (ADPKD) | Phase 2 | Status: ACTIVE_NOT_RECRUITING